These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 29856958)
1. A Hematogenous Route for Medulloblastoma Leptomeningeal Metastases. Garzia L; Kijima N; Morrissy AS; De Antonellis P; Guerreiro-Stucklin A; Holgado BL; Wu X; Wang X; Parsons M; Zayne K; Manno A; Kuzan-Fischer C; Nor C; Donovan LK; Liu J; Qin L; Garancher A; Liu KW; Mansouri S; Luu B; Thompson YY; Ramaswamy V; Peacock J; Farooq H; Skowron P; Shih DJH; Li A; Ensan S; Robbins CS; Cybulsky M; Mitra S; Ma Y; Moore R; Mungall A; Cho YJ; Weiss WA; Chan JA; Hawkins CE; Massimino M; Jabado N; Zapotocky M; Sumerauer D; Bouffet E; Dirks P; Tabori U; Sorensen PHB; Brastianos PK; Aldape K; Jones SJM; Marra MA; Woodgett JR; Wechsler-Reya RJ; Fults DW; Taylor MD Cell; 2018 May; 173(6):1549. PubMed ID: 29856958 [No Abstract] [Full Text] [Related]
2. Intramedullary metastasis in a case of vermian medulloblastoma. Madhugiri VS; Pandey P; Indira Devi B; Santosh V; Yasha TC Br J Neurosurg; 2012 Apr; 26(2):278-80. PubMed ID: 21970778 [TBL] [Abstract][Full Text] [Related]
3. Medulloblastoma with leptomeningeal metastases. Rasalkar DD; Chu WC; Shing MK; Li CK Hong Kong Med J; 2011 Aug; 17(4):340-1. PubMed ID: 21813908 [No Abstract] [Full Text] [Related]
4. Supratentorial leptomeningeal metastasis of a medulloblastoma without cerebellar tumor recurrence. Gerlach R; Kieslich M; van de Nes J; Galow W; Seifert V Acta Neurochir (Wien); 2002 Feb; 144(2):201-4; discussion 204. PubMed ID: 11862522 [TBL] [Abstract][Full Text] [Related]
6. Panobinostat, a histone deacetylase inhibitor, suppresses leptomeningeal seeding in a medulloblastoma animal model. Phi JH; Choi SA; Kwak PA; Lee JY; Wang KC; Hwang DW; Kim SK Oncotarget; 2017 Aug; 8(34):56747-56757. PubMed ID: 28915627 [TBL] [Abstract][Full Text] [Related]
7. Reovirus prolongs survival and reduces the frequency of spinal and leptomeningeal metastases from medulloblastoma. Yang WQ; Senger D; Muzik H; Shi ZQ; Johnson D; Brasher PM; Rewcastle NB; Hamilton M; Rutka J; Wolff J; Wetmore C; Curran T; Lee PW; Forsyth PA Cancer Res; 2003 Jun; 63(12):3162-72. PubMed ID: 12810644 [TBL] [Abstract][Full Text] [Related]
8. miR-192 suppresses leptomeningeal dissemination of medulloblastoma by modulating cell proliferation and anchoring through the regulation of DHFR, integrins, and CD47. Yang SY; Choi SA; Lee JY; Park AK; Wang KC; Phi JH; Koh EJ; Park WY; Park SH; Hwang DW; Jung HW; Kim SK Oncotarget; 2015 Dec; 6(41):43712-30. PubMed ID: 26506238 [TBL] [Abstract][Full Text] [Related]
12. Medulloblastoma: From Myth to Molecular. Ramaswamy V; Taylor MD J Clin Oncol; 2017 Jul; 35(21):2355-2363. PubMed ID: 28640708 [TBL] [Abstract][Full Text] [Related]
13. Human neural stem cells target and deliver therapeutic gene to experimental leptomeningeal medulloblastoma. Shimato S; Natsume A; Takeuchi H; Wakabayashi T; Fujii M; Ito M; Ito S; Park IH; Bang JH; Kim SU; Yoshida J Gene Ther; 2007 Aug; 14(15):1132-42. PubMed ID: 17508009 [TBL] [Abstract][Full Text] [Related]
15. Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee. Warren KE; Vezina G; Poussaint TY; Warmuth-Metz M; Chamberlain MC; Packer RJ; Brandes AA; Reiss M; Goldman S; Fisher MJ; Pollack IF; Prados MD; Wen PY; Chang SM; Dufour C; Zurakowski D; Kortmann RD; Kieran MW Neuro Oncol; 2018 Jan; 20(1):13-23. PubMed ID: 28449033 [TBL] [Abstract][Full Text] [Related]
16. Characteristics and outcomes of non-Hodgkin's lymphoma patients with leptomeningeal metastases. Meng X; Yu J; Fan Q; Li L; Li W; Song Z; Liu X; Jiang Y; Gao M; Zhang H Int J Clin Oncol; 2018 Aug; 23(4):783-789. PubMed ID: 29558001 [TBL] [Abstract][Full Text] [Related]
17. Detection of Driver and Resistance Mutations in Leptomeningeal Metastases of NSCLC by Next-Generation Sequencing of Cerebrospinal Fluid Circulating Tumor Cells. Jiang BY; Li YS; Guo WB; Zhang XC; Chen ZH; Su J; Zhong WZ; Yang XN; Yang JJ; Shao Y; Huang B; Liu YH; Zhou Q; Tu HY; Chen HJ; Wang Z; Xu CR; Wang BC; Wu SY; Gao CY; Zhang X; Wu YL Clin Cancer Res; 2017 Sep; 23(18):5480-5488. PubMed ID: 28606923 [No Abstract] [Full Text] [Related]
18. The prognostic significance of surgically treated hydrocephalus in leptomeningeal metastases. Jung TY; Chung WK; Oh IJ Clin Neurol Neurosurg; 2014 Apr; 119():80-3. PubMed ID: 24635931 [TBL] [Abstract][Full Text] [Related]
19. Intracranial leptomeningeal metastases: comparison of depiction at FLAIR and contrast-enhanced MR imaging. Singh SK; Agris JM; Leeds NE; Ginsberg LE Radiology; 2000 Oct; 217(1):50-3. PubMed ID: 11012422 [TBL] [Abstract][Full Text] [Related]
20. Treatment of leptomeningeal metastases in a rat model using a recombinant adenovirus containing the HSV-tk gene. Vincent AJ; Esandi MD; van Someren G; Noteboom JL; Avezaat CJ; Vecht C; Smitt PA; van Bekkum DW; Valerio D; Hoogerbrugge PM; Bout A J Neurosurg; 1996 Oct; 85(4):648-54. PubMed ID: 8814169 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]